MYCN and MeCP2 Interaction in Neuroblastoma
Author Information
Author(s): Derek M. Murphy, Patrick G. Buckley, Sudipto Das, Karen M. Watters, Kenneth Bryan, Raymond L. Stallings
Primary Institution: Royal College of Surgeons in Ireland
Hypothesis
The association between MYCN binding and regions of DNA hypermethylation may be due to the action of the methyl binding protein MeCP2.
Conclusion
MYCN and MeCP2 interact and co-localize at genomic sites, influencing transcriptional activity in neuroblastoma.
Supporting Evidence
- MYCN and MeCP2 co-localize to gene promoter regions in neuroblastoma.
- Co-immunoprecipitation confirmed the interaction between MYCN and MeCP2.
- Genes bound by both MYCN and MeCP2 showed intermediate expression levels.
Takeaway
This study found that two proteins, MYCN and MeCP2, work together in neuroblastoma cells, which might help us understand how this cancer develops.
Methodology
The study used chromatin immunoprecipitation and microarray analysis to examine the binding of MYCN and MeCP2 to genomic sites.
Limitations
The study does not establish a direct causal relationship between MYCN/MeCP2 interaction and neuroblastoma pathogenesis.
Participant Demographics
The study focused on the Kelly neuroblastoma cell line, derived from a female patient.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website